πŸ‡ΊπŸ‡Έ FDA
Patent

US 10858399

Peptide compositions

granted A61KA61K38/00A61K38/12

Quick answer

US patent 10858399 (Peptide compositions) held by RHYTHM PHARMACEUTICALS, INC. expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RHYTHM PHARMACEUTICALS, INC.
Grant date
Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61K38/12, A61P, A61P1/16